医学臭氧通过一种新的共享机制增加了在类风湿性关节炎中甲甲酸的作用,该机制涉及腺素
Olga Sonia León Fernández1, Gabriel Takon Oru1, Renate Viebahn-Haensler2
1Pharmacy and Food Institute, University of Havana, Havana 13603, Cuba.
International journal of molecular sciences
|June 13, 2025
概括
医疗臭氧和甲状腺素合疗法在类风湿性关节炎 (RA) 中表现有前途. 这种治疗通过向腺受体来减少氧化应激和炎症,为RA管理提供了一种新的方法.
科学领域:
- * 免疫学和药理学
- * 风湿病学和氧化应激研究
背景情况:
- *类风湿性关节炎 (RA) 是一种自身免疫性疾病,其特点是氧化应激和炎症.
- * 医学臭氧作为氧化还原调节剂,在具有氧化病因的疾病中具有潜在的治疗益处.
- *反应性氧物种 (ROS) 在RA的病理途径中起着重要作用.
研究的目的:
- * 审查在模型疾病和临床RA反应中对臭氧的药理学试验.
- * 探索ROS和RA病理途径之间的关系.
- * 调查医学臭氧和甲状腺 (MTX) 在 RA 治疗中的潜在共享机制.
主要方法:
- * 涉及臭氧治疗的药理学试验的整体综述.
- *对实验动物数据和RA患者的临床发现进行综合分析.
- * 检查反应性氧物种 (ROS) 和腺路径在RA病变发生中的作用.
主要成果:
- * 甲基 (MTX) 和医疗臭氧通过腺能调节共享共同的治疗机制.
- *MTX和医疗臭氧的联合治疗有效地减少了ROS的过度产量.
- * 联合治疗降低了促炎性细胞因子和抗循环氨酸水平的产生.
结论:
- * 建议使用一种新的药理机制来治疗RA,该机制包括MTX和医学臭氧治疗的联合治疗.
- * 结合疗法通过涉及腺A1受体的相互机制起作用.
- *这种方法有效调节了类风湿性关节炎的关键炎症和氧化应激标志物.
相关概念视频
Phase II Reactions: Methylation Reactions
164
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
164
Antiasthma Drugs: Methylxanthines
211
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
211
Antiasthma Drugs: Leukotriene Modifiers
260
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
260
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Electron Transport Chain: Complex I and II
12.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.4K
Antiasthma Drugs: Muscarinic Receptor Antagonists
265
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
265


